AIkido Pharma (AIKI) Insider Trading & Ownership $1.23 +0.14 (+12.84%) As of 01/17/2025 Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsTrends AIkido Pharma (NASDAQ:AIKI) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage8.60%Number OfInsiders Buying(Last 3 Years)3Amount OfInsider Buying(Last 3 Years)$665,262.09Number OfInsiders Selling(Last 3 Years)0 Get AIKI Insider Trade Alerts Want to know when executives and insiders are buying or selling AIkido Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address AIKI Insider Buying and Selling by Quarter AIkido Pharma Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/19/2022Kyle Michael WoolDirectorBuy5,000$3.59$17,950.00 12/15/2022Kyle Michael WoolDirectorBuy5,000$3.69$18,450.00 12/14/2022Anthony HayesCEOBuy4,500$3.69$16,605.00 12/12/2022Anthony HayesCEOBuy5,000$3.62$18,100.00 12/9/2022Anthony HayesCEOBuy5,000$3.68$18,400.00 12/7/2022Anthony HayesCEOBuy5,000$3.48$17,400.00 9/16/2022Kyle Michael WoolDirectorBuy3,559$6.54$23,275.86 9/14/2022Soo YuDirectorBuy1,477$6.12$9,039.24 9/12/2022Anthony HayesCEOBuy38,208$6.33$241,856.64 9/12/2022Soo YuDirectorBuy44,895$6.33$284,185.35 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. (Data available from 1/1/2013 forward) AIKI Insider Trading Activity - Frequently Asked Questions Who is on AIkido Pharma's Insider Roster? The list of insiders at AIkido Pharma includes Anthony Hayes, Kyle Michael Wool, and Soo Yu. Learn more on insiders at AIKI. What percentage of AIkido Pharma stock is owned by insiders? 8.60% of AIkido Pharma stock is owned by insiders. Learn more on AIKI's insider holdings. AIkido Pharma Key ExecutivesMr. Anthony C. Hayes Esq. (Age 54)CEO, Principal Financial Officer, Principal Accounting Officer & Director Compensation: $960kMr. Darrell DotsonVP of Drug Devel. & Gen. CounselMr. Carlos AldaveroPres of Dominari Financial More Insider Trading Tools from MarketBeat Related Companies iSpecimen Insider Selling IQVIA Insider Selling ICON Public Insider Selling Incyte Insider Selling Medpace Insider Selling Charles River Laboratories International Insider Selling MaxCyte Insider Selling OmniAb Insider Selling National Research Insider Selling Absci Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Strong Capital Returns and Insider Buying SignalsZymeworks in Focus for Insider Activity: Catalysts AheadInsiders Are Loading Up: 3 Key Stock Picks for InvestorsInsiders Are Selling, But These 3 Stocks Are Must-Buys3 Stocks That Wall Street Insiders Can’t Stop Buying This page (NASDAQ:AIKI) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump currency shock imminentTrump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launc...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredThe Crypto Secret Wall Street Doesn’t Want You to KnowPotential $20-trillion opportunity? Put $500 into THIS AI Coin for 2025… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AIkido Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AIkido Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
